CON-TGO91-254 - Novartis Pharmaceuticals Australia Pty Ltd
Product names
- AUST R 160228 - RITALIN LA methylphenidate hydrochloride 10 mg modified release capsule bottle
- batches: APCC645; APCC708
- AUST R 82957 - RITALIN LA methylphenidate hydrochloride 20mg modified release capsule bottle
- batches: APCC865, APCC705
- AUST R 82958 - RITALIN LA methylphenidate hydrochloride 30mg modified release capsule bottle
- batch: APCC660
- AUST R 82959 - RITALIN LA methylphenidate hydrochloride 40mg modified release capsule bottle
- batches: APCC683; APCC707
- AUST R 236251 - RITALIN LA methylphenidate hydrochloride 60mg modified release capsules bottle
- batches: APCC819, APCC840
Decision Date
Duration
The duration of consent is for the batches specified above.
Non-compliance with standard
The product(s) do not conform with the requirements of TGO 91 but are supplied with label(s) that have been approved by the TGA.
Supply/Import or Export
Supply
Therapeutic good type
Prescription medicines